Profile

Eric M. Meslin has had a diverse 35-year career in clinical, academic, government, and not-for profit settings, the common thread throughout has been a focus on the ethical, social and policy implications of health, science, and technology. In 2023 he stepped downafter 8 years as President and CEO of the Council of Canadian Academies. Prior leadership positions included Bioethics Research Director of the Ethical, Legal, and Social Implications (ELSI) program at the National Human Genome Research Institute in the early years of the Human Genome Project, and Executive Director of the U.S. National Bioethics Advisory Commission established by President Bill Clinton. His academic resume includes 15 years as Founding Director of the Indiana University Center for Bioethics, Associate Dean for Bioethics in the IU School of Medicine, tenured Full Professor of Medicine, and of Philosophy and IU’s first Endowed Professor of Bioethics. He has held academic positions at University of Western Australia and  Université de Toulouse. He is currently Adjunct Professor in the Dalla Lana School of Public Health, University of Toronto; Distinguished Research Scholar, Institute for Bioethics and Health Policy, University of Miami; Senior Fellow, PHG Foundation, University of Cambridge.

He has been an advisor to and advisory committee member for several organizations including the World Health Organization, ELIXIR-Europe, OECD, Genome Canada, US National Institutes of Health, Standards Council of Canada, and UK Biobank.

Among his honours, Dr. Meslin is a Fellow of the Royal Society of Canada, Canadian Academy of Health Sciences, the Hastings Center,  and a Chevalier de L’Ordre Nationale du Mérite (Knight of the National Order of Merit) for his contributions to French bioethics policy.

---